Shariq Omair A, Bancos Irina, Cronin Patricia A, Farley David R, Richards Melanie L, Thompson Geoffrey B, Young William F, McKenzie Travis J
Department of Surgery, Mayo Clinic, Rochester, MN.
Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic, Rochester, MN.
Surgery. 2018 Jan;163(1):183-190. doi: 10.1016/j.surg.2017.07.034. Epub 2017 Nov 9.
We aimed to determine whether a greater degree of contralateral suppression of aldosterone secretion at adrenal venous sampling predicted the development of postoperative hyperkalemia after unilateral adrenalectomy for primary aldosteronism.
A retrospective analysis of patients undergoing unilateral adrenalectomy for primary aldosteronism between 2004-2015 was performed. Clinical and biochemical parameters of patients who developed hyperkalemia (≥5.2 mmol/L) after unilateral adreanlectomy were compared with those who remained normokalemic. The contralateral suppression index was defined as the aldosterone-to-cortisol ratio from the nondominant adrenal vein divided by the aldosterone-to-cortisol ratio from the external iliac vein.
Of 192 patients who met criteria for inclusion, 12 (6.3%) developed hyperkalemia (median serum potassium 5.5 mmol/L, range 5.2-6.2 mmol/L), with a median time to onset of 13.5 days (range 7-55 days). Five patients had transiently increased serum potassium concentrations that normalized spontaneously. Four patients received mineralocorticoid replacement therapy with fludrocortisone. On univariate analysis, hyperkalemic patients had slightly greater preoperative serum creatinine levels (1.2 vs 1.0 mg/dL, P = .01), higher postoperative creatinine (1.3 vs 1.0 mg/dL, P = .02), lesser median contralateral suppression index (0.14 vs 0.27, P = .03), and larger adenomas (1.9 vs 1.4 cm, P = .02). On multivariable logistic regression, the contralateral suppression index remained the only significant predictor of postoperative hyperkalemia (P = .04) with an optimal cut-off of <0.47.
Hyperkalemia after unilateral adrenalectomy for primary aldosteronism is uncommon and usually transient, but may require mineralocorticoid supplementation. Patients with a contralateral suppression index of <0.47 require meticulous follow-up and monitoring of serum potassium concentrations after unilateral adrenalectomy.
我们旨在确定在肾上腺静脉采血时,醛固酮分泌的对侧抑制程度更高是否能预测原发性醛固酮增多症单侧肾上腺切除术后高钾血症的发生。
对2004年至2015年间接受原发性醛固酮增多症单侧肾上腺切除术的患者进行回顾性分析。将单侧肾上腺切除术后发生高钾血症(≥5.2 mmol/L)的患者的临床和生化参数与血钾正常的患者进行比较。对侧抑制指数定义为非优势肾上腺静脉的醛固酮与皮质醇比值除以髂外静脉的醛固酮与皮质醇比值。
在192例符合纳入标准的患者中,12例(6.3%)发生高钾血症(血清钾中位数5.5 mmol/L,范围5.2 - 6.2 mmol/L),发病中位时间为13.5天(范围7 - 55天)。5例患者血清钾浓度短暂升高后自发恢复正常。4例患者接受了氟氢可的松盐皮质激素替代治疗。单因素分析显示,高钾血症患者术前血清肌酐水平略高(1.2 vs 1.0 mg/dL,P = 0.01),术后肌酐水平更高(1.3 vs 1.0 mg/dL,P = 0.02),对侧抑制指数中位数更低(0.14 vs 0.27,P = 0.03),腺瘤更大(1.9 vs 1.4 cm,P = 0.02)。多变量逻辑回归分析显示,对侧抑制指数仍然是术后高钾血症的唯一显著预测因素(P = 0.04),最佳截断值<0.47。
原发性醛固酮增多症单侧肾上腺切除术后高钾血症并不常见,通常是短暂的,但可能需要补充盐皮质激素。对侧抑制指数<0.47的患者在单侧肾上腺切除术后需要密切随访并监测血清钾浓度。